By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



11095 Flintkote Avenue
Suite D
San Diego  California  92121  U.S.A.
Phone: Fax:



Company News
Ignyta (RXDX) Announces Issuance Of Patent Covering Composition Of Matter Of RXDX-107 10/7/2015 1:14:39 PM
Ignyta (RXDX) Announces Updated Interim Data From Entrectinib Phase 1 Clinical Trials At The 2015 European Cancer Congress 9/28/2015 1:33:58 PM
Ignyta (RXDX) To Present At Ladenburg Thalmann Life Sciences Conference 9/23/2015 11:00:42 AM
Ignyta (RXDX) Announces Entrectinib Phase I Data Presentation At The 2015 European Cancer Congress 9/21/2015 11:29:39 AM
Ignyta (RXDX) Announces Initiation Of Phase 1/1b Clinical Trial Of RXDX-107 9/18/2015 9:36:19 AM
Ignyta (RXDX) Appoints Igor Bilinsky As General Manager, Immuno-Oncology And Senior Vice President, Special Operations 9/17/2015 10:51:57 AM
Ignyta (RXDX) Appoints Valerie Harding As Senior Vice President, Chemistry, Manufacturing, And Controls 9/2/2015 10:29:52 AM
Ignyta (RXDX) Announces Entrectinib Clinical Case Report Presentation At The 2015 World Conference On Lung Cancer 9/2/2015 10:24:00 AM
Ignyta (RXDX) Reports Granting Of Inducement Awards 8/20/2015 8:50:04 AM
Ignyta (RXDX) Announces Second Quarter 2015 Company Highlights And Financial Results 8/11/2015 10:57:31 AM